IONIS-FB-LRx

Age-related Macular Degeneration // Clinical Trials // Kimberly Stepien // Past // Jun 12 2019

The purpose of the study is to evaluate the effect of IONIS-FB-LRx on the rate of change of the area of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) measured by fundus autofluorescence (FAF).

Sponsor: Ionis Pharmaceuticals, Inc.

clinicaltrials.gov